Overexpression of Prothymosin Alpha in Liver Cancer
Author Information
Author(s): C-G Wu, NA Habib, RR Mitry, PH Reitsma, SJH van Deventer, RAFM Chamuleau
Primary Institution: Academic Medical Center, University of Amsterdam
Hypothesis
Is the overexpression of prothymosin alpha correlated with c-myc in patients with hepatocellular carcinoma (HCC)?
Conclusion
Prothymosin alpha mRNA levels are significantly higher in patients with HCC and are correlated with c-myc expression.
Supporting Evidence
- Prothymosin alpha mRNA levels were two- to 9.2-fold higher in tumoral tissues than in adjacent non-tumoral tissues in 14 of 17 patients with HCC.
- c-myc mRNA amounts were two- to fivefold increased in 11 of 17 patients with HCC.
- In situ hybridization revealed that increased prothymosin alpha mRNA was localized in the tumor nodules of patients with HCC.
Takeaway
This study found that a protein called prothymosin alpha is much more present in liver cancer tissues than in healthy tissues, which might help doctors identify liver cancer earlier.
Methodology
The study analyzed mRNA levels of prothymosin alpha and c-myc in liver tissue samples from patients with HCC, cirrhosis, adenoma, and healthy controls using Northern blot analysis.
Limitations
The study had a limited number of patients, which may affect the generalizability of the findings.
Participant Demographics
Patients included 17 individuals with HCC (10 with cirrhosis, 7 without), 4 with hepatic adenoma, 6 with cirrhosis only, and 3 healthy controls.
Statistical Information
P-Value
< 0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website